These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 10639448)

  • 1. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.
    Briles DE; Ades E; Paton JC; Sampson JS; Carlone GM; Huebner RC; Virolainen A; Swiatlo E; Hollingshead SK
    Infect Immun; 2000 Feb; 68(2):796-800. PubMed ID: 10639448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
    Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
    Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae.
    Wu HY; Nahm MH; Guo Y; Russell MW; Briles DE
    J Infect Dis; 1997 Apr; 175(4):839-46. PubMed ID: 9086139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
    Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
    Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
    Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
    Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
    Miyaji EN; Dias WO; Gamberini M; Gebara VC; Schenkman RP; Wild J; Riedl P; Reimann J; Schirmbeck R; Leite LC
    Vaccine; 2001 Dec; 20(5-6):805-12. PubMed ID: 11738744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children.
    Zhang Q; Choo S; Finn A
    Infect Immun; 2002 Oct; 70(10):5363-9. PubMed ID: 12228260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection.
    Briles DE; Hollingshead S; Brooks-Walter A; Nabors GS; Ferguson L; Schilling M; Gravenstein S; Braun P; King J; Swift A
    Vaccine; 2000 Feb; 18(16):1707-11. PubMed ID: 10689153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant.
    Chen X; Li B; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Zhang Y; Wu Y
    Med Microbiol Immunol; 2019 Apr; 208(2):215-226. PubMed ID: 30707297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and mucosal protective immunity to pneumococcal surface protein A.
    Briles DE; Tart RC; Wu HY; Ralph BA; Russell MW; McDaniel LS
    Ann N Y Acad Sci; 1996 Oct; 797():118-26. PubMed ID: 8993356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.
    Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y
    Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.
    Richards L; Ferreira DM; Miyaji EN; Andrew PW; Kadioglu A
    Immunobiology; 2010 Apr; 215(4):251-63. PubMed ID: 20071053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.
    Balachandran P; Brooks-Walter A; Virolainen-Julkunen A; Hollingshead SK; Briles DE
    Infect Immun; 2002 May; 70(5):2526-34. PubMed ID: 11953392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).
    Talkington DF; Brown BG; Tharpe JA; Koenig A; Russell H
    Microb Pathog; 1996 Jul; 21(1):17-22. PubMed ID: 8827703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the targets of cross-reactive antibodies induced by Streptococcus pneumoniae colonization.
    Roche AM; Weiser JN
    Infect Immun; 2010 May; 78(5):2231-9. PubMed ID: 20231407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
    Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage.
    Holmlund E; Quiambao B; Ollgren J; Nohynek H; Käyhty H
    Vaccine; 2006 Jan; 24(1):57-65. PubMed ID: 16115703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J; Chen X; Li B; Gu T; Meng X; Kong W; Wu Y
    Immunol Res; 2018 Aug; 66(4):528-536. PubMed ID: 30128745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Strategy To Protect against Influenza Virus-Induced Pneumococcal Disease without Interfering with Commensal Colonization.
    Greene CJ; Marks LR; Hu JC; Reddinger R; Mandell L; Roche-Hakansson H; King-Lyons ND; Connell TD; Hakansson AP
    Infect Immun; 2016 Jun; 84(6):1693-1703. PubMed ID: 27001538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli.
    De BK; Sampson JS; Ades EW; Huebner RC; Jue DL; Johnson SE; Espina M; Stinson AR; Briles DE; Carlone GM
    Vaccine; 2000 Mar; 18(17):1811-21. PubMed ID: 10699329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.